(Total Views: 523)
Posted On: 01/23/2020 4:51:54 PM
Post# of 153911
Hello trapac-
I'm more conservative in expectations than most here, so IMO, BLA is already priced in. In a vacuum, perhaps there is a small bump as a sigh of relief after a months of delays, but there is an extremely high likelihood of approval on the BLA and we all know that. I do buy the notion that the BLA could be the trigger for financing or just putting more light on the stock and pushing the price.
The Breakthrough Therapy Designation should be the real Breakthrough in unlocking the company value. To get there, you would have to assume we have demonstrated to the FDA that the drug works against cancer based on hard data. If that happens, who knows where this thing goes.
I'm more conservative in expectations than most here, so IMO, BLA is already priced in. In a vacuum, perhaps there is a small bump as a sigh of relief after a months of delays, but there is an extremely high likelihood of approval on the BLA and we all know that. I do buy the notion that the BLA could be the trigger for financing or just putting more light on the stock and pushing the price.
The Breakthrough Therapy Designation should be the real Breakthrough in unlocking the company value. To get there, you would have to assume we have demonstrated to the FDA that the drug works against cancer based on hard data. If that happens, who knows where this thing goes.
(1)
(0)
